[HTML] springer.com

[HTML][HTML] Increased metabolic potential, efficacy, and safety of emerging treatments in schizophrenia

JM Meyer, CU Correll - CNS drugs, 2023 - Springer
Patients with schizophrenia experience a broad range of detrimental health outcomes
resulting from illness severity, heterogeneity of disease, lifestyle behaviors, and adverse …
被引用次数：6 相关文章
[HTML] nih.gov

[HTML][HTML] Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia

JM Meyer, CU Correll - CNS Drugs, 2023 - ncbi.nlm.nih.gov
Patients with schizophrenia experience a broad range of detrimental health outcomes
resulting from illness severity, heterogeneity of disease, lifestyle behaviors, and adverse …

Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia.

C Correll, J Meyer - CNS Drugs, 2023 - escholarship.org
Patients with schizophrenia experience a broad range of detrimental health outcomes
resulting from illness severity, heterogeneity of disease, lifestyle behaviors, and adverse …

Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia

JM Meyer, CU Correll - CNS drugs - pubmed.ncbi.nlm.nih.gov
Patients with schizophrenia experience a broad range of detrimental health outcomes
resulting from illness severity, heterogeneity of disease, lifestyle behaviors, and adverse …

Increased metabolic potential, efficacy, and safety of emerging treatments in schizophrenia.

JM Meyer, CU Correll - CNS Drugs, 2023 - psycnet.apa.org
Patients with schizophrenia experience a broad range of detrimental health outcomes
resulting from illness severity, heterogeneity of disease, lifestyle behaviors, and adverse …